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Generation of Melanocytes from Induced
Pluripotent Stem Cells
Ruifeng Yang1,4, Min Jiang1,2,4, Suresh M. Kumar1, Theodore Xu1, Fei Wang3, Leihong Xiang2 and Xiaowei Xu1
Epidermal melanocytes have an important role in protecting skin from UV rays, and are implicated in a variety
of skin diseases. Here, we developed an efficient method for differentiating induced pluripotent stem
cells (iPSCs) into melanocytes. We first generated iPSCs from adult mouse tail-tip fibroblasts (TTFs) using
retroviral vectors or virus-free piggyBac transposon vectors carrying murine Sox2, Oct3/4, c-Myc, and Klf4.
The TTF-derived iPSC clones exhibited similar morphology and growth properties as mouse embryonic stem
(ES) cells. The iPSCs expressed ES cell markers, displayed characteristic epigenetic changes, and formed
teratomas with all three germ layers. The iPSCs were used to generate embryonic bodies and were
then successfully differentiated into melanocytes by treatment with growth factors. The iPSC-derived
melanocytes expressed characteristic melanocyte markers and produced melanin pigment. Electron microscopy
showed that the melanocytes contained mature melanosomes. We manipulated the conditions used to
differentiate iPSCs to melanocytes and discovered that Wnt3a is not required for mouse melanocyte
differentiation. This report shows that melanocytes can be readily generated from iPSCs, providing a powerful
resource for the in vitro study of melanocyte developmental biology and diseases. By inducing iPSCs without
viruses, the possibility of integration mutagenesis is alleviated, and these iPSCs are more compatible for cell
replacement therapies.
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INTRODUCTION
The generation of induced pluripotent stem cells (iPSCs) from
adult somatic cells by introducing only four transcription
factors, c-Myc, Klf4, Oct4, and Sox2 or Lin28, Nanog, Oct4,
and Sox2, represents a remarkable breakthrough in stem cell
research (Takahashi and Yamanaka, 2006; Okita et al., 2007;
Wernig et al., 2007; Yu et al., 2007). The resulting iPSCs
resemble embryonic stem (ES) cells in their properties and
potential to differentiate into a variety of adult cell types. iPSC
technology is a powerful tool that can be used to understand the
underlying mechanisms for disease initiation and progression or
to develop customized cellular therapies to treat certain human
diseases (Hanna et al., 2007; Dimos et al., 2008; Soldner et al.,
2009). The therapeutic use of cells derived from a patient’s own
iPSCs would avoid the complication of immune rejection,
which might occur if cells were derived from allogeneic human
ES cells. Nevertheless, there are still many practical issues with
iPSCs that need to be resolved before this breakthrough
technology can be used clinically (Yamanaka, 2010).
The most commonly used reprogramming strategies use
retroviral- or lentiviral-based methods to deliver reprogram-
ming factor transgenes and have been shown to be highly
efficient (Okita et al., 2007; Wernig et al., 2007; Yu et al.,
2007). Although efficient, these methods also have the
potential to induce insertional mutagenesis. Other methods
using adenovirus, plasmids, synthetic protein, or RNA
minimize the potential for insertional mutagenesis (Kaji
et al., 2009; Kim et al., 2009; Yu et al., 2009; Zhou and
Freed, 2009), but are less efficient. A newer technique called
piggyBac (PB) transposition is host-factor independent and
is functional in various human and mouse cell lines (Fraser
et al., 1996; Ding et al., 2005; Wu et al., 2006; Wang et al.,
2008; Woltjen et al., 2009). The PB transposon-based method
has been used successfully to reprogram adult somatic cells
to iPSCs and the transgenes can be excised after successful
reprogramming (Woltjen et al., 2009).
A concern with using iPSCs in medical and developmental
studies is the tendency of these cells to spontaneously
differentiate along different lineages. Although substantial
progress has been made in differentiating iPSCs into certain
cell types (Zhang et al., 2009; Lee et al., 2010; Itzhaki et al.,
2011; Morishima et al., 2011; Sancho-Bru et al., 2011), there
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is still a need to develop the methods and conditions
necessary to reproducibly generate homogenous populations
of distinct cell lineages from iPSCs.
Melanocytes have a critical role in protecting human
skin from harmful UV rays (Slominski et al., 2004). Their
primary function is to produce melanin pigment, which is
packaged into vesicles called melanosomes, and transported
to the surrounding epidermal keratinocytes (Halaban et al.,
1988). Vitiligo is a common melanocyte-related disorder
characterized by well-marginated milky white spots on the
skin that result from the loss of melanocytes (van Geel et al.,
2001). The study of iPSC-derived melanocytes may lead to a
better understanding of melanocyte-related diseases, such
as vitiligo, as well as melanocyte molecular biology. These
cells may also help us understand the etiology of melanoma,
the most deadly form of skin cancer.
In this study, we generated iPSCs from adult mouse tail-tip
fibroblasts (TTFs) using conventional retroviral and virus-free
plasmid-based methods. We optimized the differentiation
conditions to generate mouse melanocytes from iPSCs and
we discovered that mouse and human melanocyte differ-
entiation requires different growth factors.
RESULTS
Generation of iPSCs from mouse adult fibroblasts
To generate mouse iPSCs, mouse TTFs were isolated and
infected with retroviral vectors encoding four reprogramming
factors (Oct3/4, Sox2, Klf4, and c-Myc). iPSC clones with
ES-like morphology became apparent after 11 days and were
harvested by 21 days (Figure 1a). The efficiency of generating
established iPSCs from TTFs was 0.5–0.8% (data not shown).
Alkaline phosphatase activity is an ES cell marker and we
performed alkaline phosphatase staining and showed that
most of the iPSC clones were positive for this stain (Figure
1a). Reverse transcriptase-PCR was performed to examine
whether ES cell marker genes were expressed in iPSC cells.
We used primers designed to amplify transcripts of endo-
genous genes but not transcripts of transgenes (Takahashi
and Yamanaka, 2006). Five different iPSC clones expressed
all ES cell markers tested, and the endogenous Oct3/4, Sox2,
andNanog levels were similar to the levels found in authentic
mouse ES cells (Figure 1b). The five iPSC clones showed
similar gene expression patterns. The expressions of Nanog
and ES cell membrane marker SSEA-1 (stage-specific embry-
onic antigen-1) expression were confirmed by immuno-
fluorescence analysis of the iPSC clones (Figure 1c). We
compared the growth rates of iPSCs with ES cells and
fibroblasts and found that two of the iPSC clones displayed
exponential growth rates, similar to ES cells, whereas the TTF
cells stopped growing after 3 weeks (Figure 1d).
Characterization of iPSCs and their pluripotency
To investigate the DNA methylation status of the Oct4
and Nanog promoters, we performed bisulfite DNA sequen-
cing analysis of ES cells, iPSCs, and TTFs, respectively. As
shown in Figure 2a, both loci were demethylated in ES and
iPSCs and fully methylated in TTFs. Meanwhile, chromatin
immunoprecipitation analysis was performed to examine
chromatin histone modifications. The results showed that the
promoters of Oct4 and Nanog had increased histone H3
acetylation and dimethylation of lysine 4 of histone H3
(Figure 2b). Our results indicate that the epigenetic state of
the Oct4 and Nanog genes in the iPSCs is reprogrammed
from a transcriptionally repressed state (somatic) to an active
(embryonic) state.
To determine the pluripotency of iPSCs, we performed
in vitro differentiation assays and found that iPSCs have the
ability to differentiate into three germ layer-derived cell
types. The assay used keratin14 as a marker for ectoderm
differentiation, smooth muscle actin to mark mesoderm
differentiation, and a-fetal protein for endoderm differentia-
tion (Figure 2c). We then determined the developmental
potential of iPSCs in vivo using a teratoma formation assay.
Histological analysis of iPSC-induced teratomas revealed
that the cells had differentiated into cell types representing
all three embryonic germ layers. These teratomas contained
keratinocytes and nerve tissue (ectoderm), smooth muscle
and cartilage (mesoderm), and respiratory epithelium and gut
epithelium (endoderm; Figure 3).
Differentiation of iPSCs into melanocytes
The melanocytic differentiation protocol is illustrated in
Figure 4a. Briefly, we generated embryonic bodies (EBs)
from single iPSCs in suspended culture (Figure 4b). The EBs
were pretreated with retinoic acid and plated onto fibro-
nectin-coated plates containing complete differentiation
media containing multiple growth factors including Wnt3a,
stem cell factor (SCF), and endothelin-3 (ET-3; described
in Materials and Methods). After 24 hours, some of the cells
migrated out of the EBs. Within 4–6 days, rare, highly pig-
mented cells were observed near the EBs. After an additional
4–6 days in culture, the migrated cells continued to prolifer-
ate and reached 60–70% confluence focally (Figure 4c).
These iPSC-derived pigmented cells obtained at day 16 had
a melanocyte-like bipolar or tripolar morphology (Figure 4d)
and retained their melanin granules after 40 days of culture
in vitro (Figure 4e).
Characterization of iPSC-derived melanocytes
Although the production of melanin and the formation of
melanosomes are the most unique features of melanocytes,
there are also several melanocyte-specific gene markers.
Therefore, quantitative reverse transcriptase-PCR was per-
formed to determine whether differentiated iPSCs expressed
melanocytic markers. The results showed that undifferen-
tiated iPSCs or EBs from iPSCs expressed few melanocytic
markers, whereas melan-a melanocytes and iPSC-derived
melanocytes obtained at day 40 expressed melanocytic
markers and transcription factors associated with melanocyte
development, including Pax3, MITF-M, TYR, TYRP1, TYRP2,
SILV (Silver/Pmel17), Gpr143(Oa1), p (pink-eyed dilution
gene/Oca2), and Sox10 (Figure 5a). Immunofluorescence
analysis revealed that these cells were also strongly positive
for MITF, S-100, and TYRP2 (Figure 5b). As expected, the
MITF transcription factor localized in the nucleus, and S100
and TYRP2 were both in the cytoplasm. The DOPA reaction
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assay was used to confirm that these differentiated cells did
indeed contain tyrosinase activity (Figure 5c). To detect the
presence of melanosomes, we performed electron micros-
copy and found many mature stage III and stage IV melano-
somes in iPSC-derived melanocytes (Figure 5d).
To optimize the efficiency of melanocyte differentiation,
we tested the effects of different components of the
differentiation medium, both individually and in combina-
tions. It has already been shown that growth factors, such as
SCF, ET-3, and basic fibroblast growth factor (bFGF), are
important regulators of stem cell proliferation and neural
crest lineage differentiation (Nishikawa et al., 1991; Baynash
et al., 1994; Okura et al., 1995; Imokawa et al., 1998). To test
the effect of the different components, we measured the
surface area of migrating cells from the EBs, as well as the
percentage of pigmented cells in the migrating cells, as
described previously (Fang et al., 2006). Both the surface area
of migrating cells from EBs and the efficiency of melanocyte
generation were decreased in the absence of ET-3/SCF or
bFGF (Figure 5e and f). We have previously shown that the
Wnt pathway has a critical role in human melanocyte
differentiation from ES cells (Fang et al., 2006). In contrast,
in these experiments, we found that Wnt3a was not
indispensable in mouse melanocyte induction; no significant
inhibition was observed in the absence of Wnt3a. Similarly,
no significant inhibition was observed in the absence of
cholera toxin. The 12-O-tetradecanoylphorbol-13-acetate
(TPA) is a powerful activator of protein kinase C, and it is
extensively used in melanocyte culture (Seger and Krebs,
1995). Unexpectedly, mouse iPSCs formed smaller EB masses
and generated fewer pigmented cells when TPA was added
into the medium, suggesting that mouse iPSCs are more
sensitive to the cytotoxicity of TPA than human ES/iPSCs.
Interestingly, we found this inhibitory effect only at the early
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Figure 1. Generation and expression analysis of induced pluripotent stem cells (iPSCs). (a) Morphology of mouse iPSCs and tail-tip fibroblasts (TTFs).
(Upper panel) Morphology of mouse TTFs and iPSCs derived from TTFs; bar¼ 150 mm. (Lower panel) Alkaline phosphatase (AP) staining results of iPSC clones;
left side, bar¼ 10mm; right side, bar¼ 500mm. (b) Reverse transcriptase-PCR (RT-PCR) analysis of embryonic stem (ES) cell marker genes in mouse iPSCs,
ES cells, and TTFs. Nat1 was used as a loading control. (c) iPSCs were stained with a mouse mAb against SSEA-1 (stage-specific embryonic antigen-1) or Nanog.
As a nuclear marker, 4,6-diamidino-2-phenylindole (DAPI) staining was used. Bar¼ 500mm. (d) Growth curves of TTFs, mouse ES cells, and iPSCs. A total
of 3 105 cells were passaged every 3 days into each well of a six-well plate.
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stage of melanocyte induction (within the first 2 to 3 weeks),
whereas cells from later stages and from subsequent passages
were resistant to TPA cytotoxicity (data not shown).
Generation of melanocytes from iPSCs obtained with
virus-free system
Generation of iPSCs with genome-integrating viruses may
cause insertional mutagenesis and unpredictable genetic
dysfunction, which makes them unstable for clinical trial
and regenerative medicine. To obtain virus-free iPSCs, we
used a PB transposon/transposase-induced system (Woltjen
et al., 2009). In this system, mouse embryonic fibroblast
(MEF) cells (Figure 6a) were transfected with PB-CAG-rtTA
and PB-TET-MKOS (c-Myc, Klf4, Oct4, and Sox2 open
reading frames linked with 2A peptide sequences). With
doxycycline induction, iPSC clones with ES cell-like morpho-
logy appeared 14 days later and were picked up by 30 days
(Figure 6a). Reprogramming efficiency was roughly 0.01%,
which is lower than retrovirus systems. Alkaline phosphatase
staining (Figure 6a) and immunostaining with antibodies
against Nanog and SSEA-1 (Figure 6b) showed that these cell
lines were positive for ES cell markers. Next, we performed
melanocyte differentiation assays using these virus-free iPSCs
and obtained similar results as with the iPSCs generated using
virus. Specifically, reverse transcriptase-PCR results showed
that melanocytes generated from virus-free iPSCs expressed
melanocyte markers, including MITF, TYR, TYRP1, and
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Figure 2. Epigenetic modification and in vitro differentiation of induced
pluripotent stem cells (iPSCs). (a) Bisulfite genomic sequencing of the
promoter regions of Oct3/4 and Nanog in 10 randomly selected iPSC and 10
embryonic stem (ES) cell clones, as well as mouse embryonic fibroblast
(MEF) cells. Open circles indicate unmethylated CpG dinucleotides,
whereas closed circles indicate methylated CpGs. TTF, tail-tip fibroblast.
(b) Chromatin immunoprecipitation was performed using antibodies against
dimethylated histone H3K4 (H3K4me2) and H3 acetylation (acH3). Oct3/4
and Nanog promoters showed enrichment for the active (H3K4me2 and
acH3) mark in iPSCs, similar to ES cells. In MEFs, Oct3/4 and Nanog
promoters appeared in the inactive state. (c) Differentiation of iPSCs into
three germ layer-derived cell types. Immunostaining was performed with
antibodies against keratin14 (K14) for ectoderm differentiation, smooth
muscle actin (SMA) for mesoderm differentiation, and a-fetal protein (AFP) for
endoderm differentiation. As a nuclear marker, 4,6-diamidino-2-phenylindole
(DAPI) staining was used. Bar¼15 mm.
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Figure 3. Developmental pluripotency of induced pluripotent stem cells
(iPSCs) by teratoma formation. A total of 106 iPSCs were injected into dorsal
flanks of the nude mice. At 4 weeks after the injection, tumors were removed
from the mice. Histology analysis showed that tumors from the iPSCs
contained cells derived from three germ layers, keratinocytes and nerve tissue
for ectoderm, smooth muscle and cartilage for mesoderm, and respiratory and
gut epithelium for endoderm (hematoxylin and eosin (H&E) staining).
Bar¼50 mm.
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TYRP2 (Figure 6c), indicating that virus-free iPSCs can also be
differentiated into melanocytes.
DISCUSSION
In this study, we developed an in vitro method for deriving
melanocytes from mouse iPSCs reprogrammed with four
factors (Oct3/4, Sox2, Klf4, and c-Myc). Similar to retroviral
vector-mediated reprogramming, the virus-free PB transposon
method induced reprogramming of adult TTFs. Mouse
melanocytes derived from iPSCs exhibited typical melano-
cyte morphology, synthesized melanosomes, and expressed
typical melanocyte markers. Melanocytes generated from
iPSCs could potentially be used to better understand melano-
cyte biology and reveal the underlying mechanisms of
pigmentation disorders and melanoma development.
During embryonic development, melanocytes are derived
from neural crest cells (Opdecamp et al., 1997). We
previously reported that the factors required for the induc-
tion of melanocytes from human ES cells and skin neural
crest-like stem cells include bFGF, SCF, ET-3, and Wnt3a
(Fang et al., 2006; Yu et al., 2006, 2010; Li et al., 2010).
However, in this study, we found that Wnt3a is dispensable
for mouse iPSC differentiation into melanocytes. This suggests
that different pathways may be required during mouse
and human melanocyte development. As the Wnt signaling
pathway is known to have a key role during melanocyte
induction from neural crest (Jin et al., 2001), our results
suggest the presence of an alternative Wnt factor that
substitutes for Wnt3a in mouse melanocyte development.
We also found that TPA, which functions as a growth
enhancer in melanocyte growth medium by activating the
protein kinase C pathway (Seger and Krebs, 1995), is
unnecessary for melanocyte differentiation from mouse
iPSCs. Instead, the presence of TPA inhibits melanocyte
differentiation, suggesting that initiating melanocyte differ-
entiation is distinct from promoting melanocyte proliferation
in established melanocyte cultures.
Ohta et al. (2011) recently showed that melanocytes can
be generated from human iPSCs in vitro. They generated iPSC
lines from human dermal fibroblasts using SOX2, OCT3/4,
and KLF4, with or without c-MYC in retroviral vectors. The
EBs were then cultured in melanocyte differentiation medium
containing Wnt3a, SCF, ET3, FGF-2, and cholera toxin, and
mature melanocytes were generated 7 weeks after inducing
differentiation. Our findings here are consistent with their
results. In addition, we used the viral-free PB transposon
method to generate iPSCs and optimized the differentiation
protocol for mouse melanocytes.
Defects in melanocytes can lead to a number of
pigmentation disorders, such as piebaldism, albinism,
iPSC clone
SCF, ET-3, and Wnt3aSingle cells
Fibronectin coating plates
EB
Day 0 Day 4 Day 4 Day 8
iPSC-derived
melanocytes
EBs iPSC-derived
melanocytes
Figure 4. Differentiation of melanocytes from induced pluripotent stem cells
(iPSCs). (a) Differentiation overview. Embryonic bodies (EBs) were formed
from iPSCs and treated with 1 mM retinoic acid (RA) after 2 days.
After 3 days with RA, the EBs were plated onto fibronectin-coated dishes in
melanocyte differentiation medium with endothelin-3 (ET-3), stem cell factor
(SCF), basic fibroblast growth factor (bFGF), and Wnt3a. (b) EBs formed in
suspension under feeder-free conditions; left side, bar¼10mm; right side,
bar¼ 500 mm. (c) Cell migration from EBs on a fibronectin-coated plate.
In melanocyte differentiation medium, cells migrated out from EBs at day 4
and differentiated cells appeared with morphology typical of melanocytes at
day 8 (bright-field microscopy); bar¼ 500mm. (d) At day 16, differentiated
cells displayed more homogenous melanocytic morphology after splitting
(phase-contrast microscope). Bar¼ 25mm. (e) Unpigmented EBs before
differentiation (left), in contrast to the pigmented cell pellet from iPSC-derived
melanocytes (right).
Figure 5. Characterization of melanocytes derived from induced pluripotent stem cells (iPSCs). (a) Quantitative reverse transcriptase-PCR (RT-PCR) analysis of
melanocyte markers in iPSCs, embryoid bodies (EBs) from iPSCs (iPSC-EBs), melanocytes from iPSCs (iPSC melanocytes), mouse melanocyte melan-a cells, and
tail-tip fibroblasts (TTFs), including Pax3, MITF-M, TYR, TYRP1, TYRP2, SILV (Silver/Pmel17), Gpr143(Oa1), p (pink-eyed dilution gene/Oca2), and Sox10;
GAPDH was used as a loading control. (b) Immunostaining analysis of iPSC-derived melanocytes with antibodies against MITF, S-100, and TYRP2. Bar¼15 mm
(immunofluorescent microscopy). (c) DOPA (3,4-dihydroxyphenylalanine) reaction of melanocytes derived from iPSCs. The pigmented cells represent
DOPA-positive cells. Bar¼ 30mm. (d) Electron microscopy images show an iPSCs-derived melanocyte with many mature melanosomes in the cytoplasm.
II: Stage II melanosome; III: stage III melanosome; IV: stage IV melanosome. Left side, bar¼ 1mm; right side, bar¼ 400nm. (e) Percentage of flask surface area
occupied by cells migrated out of EBs. Adherent EBs were cultured in the medium with the various growth factors in different combinations. Without SCF/ET-3
or bFGF, the surface area of migrating cells decreased, whereas no change was observed in the group without Wnt3a. In the absence of TPA, the surface
area of migrating cells covered more than the other combinations. *Po0.05 (mean±SEM n¼ 3), **Po0.01 (mean±SEM n¼ 3). bFGF, basic fibroblast
growth factor; ET-3, endothelin-3; SCF, stem cell factor; TPA, 12-O-tetradecanoylphorbol-13-acetate. (f) Efficiency of melanocyte generation from iPSCs.
Consistent with the increased area covered by migrating cells from EBs, the efficiency of melanocyte generation decreased without SCF/ETs or bFGF.
In contrast, more melanocytes were observed without TPA. *Po0.05 (mean±SEM n¼3), **Po0.01 (mean±SEM n¼ 3).
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vitiligo, and hair graying (Boissy and Nordlund, 1997).
Vitiligo is a common disease affecting B0.1–2.0% of the
world population (Alkhateeb et al., 2003). Auto-
logous melanocyte transplantation has been used to treat
persistent vitiligo with some success. However, the method
is limited by the difficulty in generating sufficient numbers
of autologous melanocytes (Czajkowski et al., 2007)
because adult melanocytes have limited proliferation capa-
city. The generation of melanocytes from neural crest-like
adult stem cells (Yu et al., 2006), ES cells, or iPSCs may
1.0
iPSCS iPSCS-EBs iPSC-melanocytes Melan-a melanocytes TTFs
0.8
0.6
0.4
0.2
0.0
Oct4 MITF-M Pax3 Sox10 Gpr143
PSILVTYRP2TYRP1TYR
3.0
MITF S-100 TYRP2
III
**
**
*
*
*
* * *
IV
II
All
No
 bF
GF
No
 CT
No
 TP
A
No
 W
nt3
a
No
 ET
3/S
CF
No
 FB
S All
No
 bF
GF
No
 CT
No
 TP
A
No
 W
nt3
a
No
 ET
3/S
CF
No
 FB
S
36
30
24
18
12
6
0
Pe
rc
en
ta
ge
 o
f 
pi
gm
en
te
d 
ce
lls
 (%
)
2.5
2.0
1.5
1.0
0.5
0.0
D
ia
m
et
er
 o
f a
tta
ch
ed
EB
 (m
m)
R
el
at
iv
e 
ex
pr
es
sio
n
1.0
0.8
0.6
0.4
0.2
0.0
1.0
0.8
0.6
0.4
0.2
0.0
1.0
0.8
0.6
0.4
0.2
0.0
1.0
0.8
0.6
0.4
0.2
0.0
1.0
0.8
0.6
0.4
0.2
0.0
1.0
0.8
0.6
0.4
0.2
0.0
0.8
0.6
0.4
0.2
0.0
0.8
0.6
0.4
0.2
0.0
0.8
0.6
0.4
0.2
0.0
R
el
at
liv
e 
ex
pr
es
sio
n
www.jidonline.org 2463
R Yang et al.
Melanocytes and iPSCs
offer a valuable resource for the treatment of vitiligo and
other skin disorders.
Melanocytes generated from autologous iPSCs have
advantages over ES cells, including a negligible chance of
immunological rejection and no concern of ethical issues.
However, iPSCs obtained by a retroviral system have the
potential for tumor genesis (Nakagawa et al., 2008). There-
fore, virus-free systems such as the PB transposon system used
in this study are more likely to produce clinical-grade iPSCs
because they alleviate the genomic integration concerns of
retroviral transgenes. Transposons are sequences of DNA that
can move or transpose themselves to new positions within
the genome of a single cell. The integration sites in human
and mouse cells typically occur within introns. PB excises
precisely from the original insertion site (Ding et al., 2005)
and the precision is evidenced by the absence
of ‘‘footprint’’ mutations at the transposon excision sites
(Wilson et al., 2007; Wang et al., 2008; Woltjen et al., 2009).
It has been shown that the PB-based reprogramming system
enables the generation of nongenetically modified human
iPSCs (Woltjen et al., 2009). Here we show that iPSCs
induced using this viral-free method can also be differen-
tiated into melanocytes.
In summary, we have developed an efficient method to
differentiate mouse melanocytes from iPSCs. Virus-free
induction of iPSCs alleviates the concern of integration
mutagenesis, although with lower reprogramming efficien-
cies. In contrast to human ES cell differentiation into
melanocytes, Wnt3a is dispensable during mouse melano-
cyte development.
MATERIALS AND METHODS
Cell culture
ES and established iPSCs were cultured on irradiated MEFs in
DMEM containing 15% fetal bovine serum, leukemia-inhibiting
factor, penicillin/streptomycin, L-glutamine, b-mercaptoethanol, and
nonessential amino acids. TTFs were isolated from C57 mice as
described previously (Takahashi et al., 2007), and cultured in DMEM
containing 10% fetal bovine serum.
Retroviral infection
Oct4, Sox2, c-Myc, and Klf4 retroviral vectors were purchased from
(Addgene, Cambridge, CA) (pMXs-Oct3/4: 13366, pMXs-Sox2:
13367, pMXs-Klf4: 13370 and pMXs-c-Myc: 13375). The day before
transduction, 293T cells were seeded at 8 106 cells per 100mm
dish. The next day, pMXs-based retroviral vectors and pCL-ECO
helper plasmids were introduced into 293T cells using the Fugene 6
transfection reagent (Roche, Mannheim, Germany) according to the
manufacturer’s recommendations. A volume of 30 ml Fugene 6
transfection reagent was diluted in 500ml DMEM and incubated for
5minutes at room temperature. Then, 9 mg retroviral vectors and 9mg
pCL-ECO were added to the mixture, which was incubated for
another 15minutes at room temperature. After incubation, the DNA/
Fugene 6 mixture was added drop by drop onto 293T cells. Cells
were then incubated overnight at 37 1C with 5% CO2. At 24 hours
after transduction, the medium was replaced. MEFs or TTFs were
seeded at 8 105 cells per 100mm dish on mitomycin C-treated
MEF feeders. After 24 hours, virus-containing supernatants derived
from these 293T cultures were filtered through a 0.45 mm cellulose
acetate filter (Millipore, Billerica, MA) and supplemented with
4mgml–1 polybrene (Sigma-Aldrich, St Louis, MO). Target cells were
incubated in the virus/polybrene-containing supernatants for
4–18 hours. After infection, the cells were replated in 10ml fresh
medium. Clones appeared 2 weeks later and were selected after 3
weeks.
Generation of iPSCs with PB transposon system
MEFs were seeded in DMEM with 10% fetal bovine serum, on
gelatinized (0.1%) six-well dishes at a density of 1.25 105 cells per
10 cm2. After 24 hours of culture, Fugene HD (Roche) was used to
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Figure 6. Generation of induced pluripotent stem cells (iPSCs) with virus-free system and characterization of melanocytes derived from virus-free iPSCs.
(a) Morphology of mouse embryonic fibroblasts (MEFs) and iPSCs. Left panel represents the morphology of MEFs; middle panel represents the morphology
of iPSCs; right panel represents alkaline phosphatase (AP) staining of a representative iPSC colony. In MEF and MEF-iPSC, bar¼ 150mm; in alkaline phosphatase
(AP) staining, bar¼ 500mm. (b) Immunostaining of iPSCs with antibodies against Nanog and SSEA-1 (stage-specific embryonic antigen-1). Bar¼ 200 mm.
DAPI, 4,6-diamidino-2-phenylindole. (c) Reverse transcriptase-PCR (RT-PCR) analysis of melanocytes derived from iPSCs. The iPSC-derived melanocytes are
positive for Pax3, Sox10, MITF-M, TYR, TYRP1, TYRP2, SILV (Silver/Pmel17), Gpr143 (Oa1), and p (pink-eyed dilution gene/Oca2).
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transfect cells with 1.2 mg of PB-TET-MKOS, 600 ng PB-CAG-rtTA,
and 200ng of pCyL43 PB transposase plasmid (normalized to 2mg
total DNA with empty pBluescriptKSþ ) in a Fugene/DNA ratio
of 8 ml:2 mg. After 24 hours, the media was supplemented with
doxycycline (day 0) and changed entirely 48 hours after trans-
fection. Cells were fed daily with doxycycline-containing media
(1.5 mgml–1). iPSC clones appeared 14 days later and were selected
after 30 days.
Reverse transcriptase-PCR for ES cell and melanocyte markers
We performed reverse transcription reactions using SuperScript III
First-Strand Synthesis kit (Invitrogen, Carlsbad, CA). PCR was
performed with PCR Master Mix (Promega, Madison, WI). The ES
cell-specific gene primer sequences have been described (Takahashi
and Yamanaka, 2006). Primer sequences for detecting melanocyte
markers are listed in Supplementary Table online.
Bisulfite genomic sequencing
Bisulfite treatment was performed using the CpGenome modification
kit (Millipore) according to the manufacturer’s recommendations. The
PCR primers used here have been described (Takahashi and
Yamanaka, 2006). Amplified products were cloned into pCR2.1-TOPO
(Invitrogen). Ten randomly selected clones were sequenced with the
M13 forward and M13 reverse primers for each gene. Sequencing was
performed at the University of Pennsylvania sequencing facility.
Immunocytochemical and immunohistochemical staining
Mouse ES cell lines and iPSC clones growing on feeder layers were
harvested and directly stained with antibodies against stage-specific
embryonic protein Nanog (Millipore) and SSEA-1 (The Develop-
mental Studies Hybridoma Bank, Iowa City, IA). Monolayer cells
were fixed with 4% paraformaldehyde and stained with primary
antibodies specific for MITF (Santa Cruz, Santa Cruz, CA), TYRP2
(polyclonal; a gift from Dr VJ Hearing, Bethesda, MD), and S100
protein (polyclonal; Dako). After washings, cells were incubated
with the appropriate FITC-labeled secondary antibodies (Dako,
Carpinteria, CA). Formalin-fixed, paraffin-embedded tissues were
used for hematoxylin/erosin staining as described previously.
Chromatin immunoprecipitation
A total of 107 iPSCs, ES cells, or TTFs were fixed with 1%
formaldehyde for 10minutes and then lysed in 1ml lysis buffer
(50mM Tris-HCl, pH 8.0, 10mM EDTA, 1% SDS, and protease
inhibitors) for 20minutes on ice. The lysate was split into three
tubes and sonicated. After 10minutes of centrifugation, the super-
natant was precleared by incubating for 4 hours at 4 1C with agarose
beads preblocked with BSA (1mg BSA for 10ml beads) in
immunoprecipitation buffer (50mM Tris-HCl, pH 8, 150mM NaCl,
2mM EDTA, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, and
protease inhibitors). A total of 100ml of precleared chromatin per
reaction diluted in 1ml immunoprecipitation buffer in the presence of
20mg antibody was used for each immunoprecipitation reaction,
according to the manufacturer’s protocol. The following antibodies
were used for this study: anti-acH3 (Millipore), anti-dimethyl K4 of H3
(Millipore), and normal rabbit IgG (Sigma-Aldrich). The precipitate
was purified and analyzed by quantitative PCR using Bio-Rad,
Hercules, CA SYBR Green quantitative PCR Master Mix. PCR primers
were described previously (Takahashi and Yamanaka, 2006).
Differentiation induction
To induce melanocytic differentiation, we developed a modified
method based on our previous work (Fang et al., 2006). Briefly, EBs
were derived from iPSCs by suspending cells in leukemia-inhibiting
factor-depleted ES medium. After 4 days, EBs were collected
and plated on 10ngml–1 fibronectin (BD, Franklin Lakes, NJ)-coated
dishes in differentiation medium, containing 45%DMEM conditioned
by L-Wnt3a cells (a kind gift from Dr Meenhard Herlyn, The Wistar
Institute, Philadelphia, PA), 45% Medium 254 (Invitrogen), 10% fetal
bovine serum (Invitrogen), 0.5mM dexamethasone (Sigma-Aldrich),
1 insulin-transferrin-selenium (Invitrogen), 1mgml–1 linoleic acid-
bovine serum albumin (Sigma-Aldrich), 104M L-ascorbic acid
(Sigma-Aldrich), 50ngml–1 SCF (R&D, Minneapolis, MN), 100nM
ET-3 (American Peptide Company, Sunnyvale, CA), 20pM cholera
toxin (Sigma-Aldrich), 50nM TPA (Sigma-Aldrich), and 4ngml–1 bFGF
(Invitrogen). Half of the medium was carefully changed every 2 days.
Electron microscopy
Cells were fixed with 2.5% glutaraldehyde and 4% paraformal-
dehyde in 0.1 M cacodylate buffer (pH 7.4) and postfixed with 1%
OsO4. Images were obtained using an electron microscope.
Statistical analysis
Data from three independent experiments, presented in Figure 5,
were analyzed. General linear modeling with repeated measures
was used to test significant differences among the different media.
In this model, total EB numbers or the surface area of adherent EBs
differentiated under each medium condition was used as dependent
variables, and medium type and time were used as the independent
variables.
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